FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

31143811000001101: Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Jan 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
96055801000001118 Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
96068301000001111 Blinatumomab 38.5micrograms powder for solution for infusion vials en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Is a Blinatumomab true Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Is a Blinatumomab false Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has dispensed dose form Powder and solvent for solution for infusion false Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has specific active ingredient Blinatumomab false Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has specific active ingredient Blinatumomab true Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Blincyto 38.5micrograms powder and solvent for solution for infusion vials (Amgen Ltd) Is a True Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials 1 vial Has VMP True Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start